<DOC>
	<DOCNO>NCT01234545</DOCNO>
	<brief_summary>This trial conduct Africa Asia . The aim study evaluate efficacy home treatment joint bleeds ( haemarthrosis ) NovoSeven® ( activate recombinant human factor VII ) patient haemophilia A B patient inhibitor .</brief_summary>
	<brief_title>Observational Study Describing Usual Clinical Practice Use NovoSeven® Home Treatment Joint Bleeds Patients With Haemophilia A B Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patients congenital haemophilia inhibitor factor VIII IX Indication activate recombinant human factor VII treatment joint bleeding locate elbow , shoulder , wrist , hip , knee , ankle Known suspect allergy study product ( ) relate product Clinically relevant coagulation disorder congenital haemophilia A B</criteria>
	<gender>Male</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>